NeoVac
Didcot · Founded 2021
About NeoVac
NeoVac is creating a revolutionary, unique and proprietary next generation lipid nanoparticles to enable RNA vaccines for various diseases.
Company Facts
- Founded: 2021
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Nov 2021)
- Website: neovac.co.uk
Social Profiles
Canonical: https://fsome.com/organization/neovac-8421533 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.